CH Lyon Sud

Running trials

• Active, not recruiting

  Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma

  NCT06353022· Phase 2· Source

• Recruiting

  Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

  NCT03003572· Source

• Active, not recruiting

  A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

  NCT01542580· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sjögren's disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy

  NCT03830788· Source

• Completed

  Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

  NCT03445845· Phase 4· Source